Journal article
Dabigatran and Warfarin in Vitamin K Antagonist–Naive and –Experienced Cohorts With Atrial Fibrillation
Abstract
BACKGROUND: The comparison of anticoagulants dabigatran and warfarin might be most equitable in vitamin K antagonist (VKA)-naive patients.
METHODS AND RESULTS: Warfarin and 2 doses of dabigatran-110 mg BID (D110) and 150 mg BID (D150)-were compared in a balanced population of VKA-naive (≤62 days of lifetime VKA exposure, with 33% never prescribed a VKA) and VKA-experienced patients with atrial fibrillation (n=18 113). For VKA-naive and …
Authors
Ezekowitz MD; Wallentin L; Connolly SJ; Parekh A; Chernick MR; Pogue J; Aikens TH; Yang S; Reilly PA; Lip GYH
Journal
Circulation, Vol. 122, No. 22, pp. 2246–2253
Publisher
Wolters Kluwer
Publication Date
November 30, 2010
DOI
10.1161/circulationaha.110.973735
ISSN
0009-7322